Article · 27 Feb 2026
ArticlePublished 30 Oct 2024
Biomarkers in Rheumatoid Arthritis: Enhancing Diagnosis and Predicting Treatment Responses
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent joint inflammation, pain, and progressive joint damage. Despite significant advances in the understanding of RA pathophysiology and treatment options, early diagnosis and predicting therapeutic responses remain major clinical challenges. Biomarkers, which can reflect the underlying disease processes, have emerged as critical tools for improving diagnostic accuracy, stratifying patients based on disease activity, and predicting treatment outcomes. This article reviews the current state of biomarkers in RA, with an emphasis on diagnostic biomarkers, prognostic markers, and biomarkers for treatment response. We explore the role of traditional biomarkers (such as rheumatoid factor and anti-citrullinated protein antibodies), emerging biomarkers (such as cytokines, microRNAs, and serum proteomics), and novel approaches in biomarker discovery. Finally, we discuss the implications of these biomarkers in personalized medicine, providing insights into how they can guide therapy choices and improve patient outcomes in RA.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Clinical Rheumatology.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Glen Hazelwood”